| |
| |
|
| Insider
Information: |
Klein Peter S |
| Relationship: |
Director |
| City: |
Redmond |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
783,768 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$199,143,219 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
783,768 |
|
|
| Total
Value |
$199,143,219 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Microsoft Corp |
MSFT |
Chief Financial Officer |
2012-09-10 |
471,016 |
|
0 |
Premium* |
|
|
F5 Networks Inc |
FFIV |
Director |
2024-03-13 |
13,024 |
|
0 |
Premium* |
|
|
Apptio Inc |
APTI |
Director |
2019-01-10 |
0 |
2017-07-27 |
0 |
Premium* |
|
|
Denali Therapeutics Inc. |
DNLI |
Director |
2023-06-01 |
15,529 |
2021-06-01 |
0 |
Premium* |
|
|
Rotor Acquisition Corp. |
ROT.U |
Director |
2023-06-14 |
265,066 |
2021-12-09 |
0 |
Premium* |
|
|
Accolade, Inc. |
ACCD |
Director |
2023-07-25 |
19,133 |
2022-05-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
54 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACCD |
Accolade, Inc. |
Director |
• • – |
2022-05-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
603 |
603 |
0 |
- |
|
| ACCD |
Accolade, Inc. |
Director |
• • – |
2022-07-21 |
4 |
OE |
$9.67 |
$25,713 |
D/D |
2,659 |
3,262 |
0 |
- |
|
| ACCD |
Accolade, Inc. |
Director |
• • – |
2022-08-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
604 |
3,866 |
0 |
- |
|
| ACCD |
Accolade, Inc. |
Director |
• • – |
2022-11-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
603 |
4,469 |
0 |
- |
|
| ACCD |
Accolade, Inc. |
Director |
• • – |
2023-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
604 |
5,073 |
0 |
- |
|
| ACCD |
Accolade, Inc. |
Director |
• • – |
2023-07-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,060 |
19,133 |
0 |
- |
|
| APTI |
Apptio Inc |
Director |
– • – |
2017-07-27 |
4 |
A |
$0.00 |
$0 |
D/D |
8,685 |
8,685 |
0 |
- |
|
| APTI |
Apptio Inc |
Director |
– • – |
2018-05-30 |
4 |
A |
$0.00 |
$0 |
D/D |
4,649 |
13,334 |
0 |
- |
|
| APTI |
Apptio Inc |
Director |
– • – |
2018-08-13 |
4 |
AS |
$35.07 |
$280,536 |
D/D |
(8,000) |
13,334 |
0 |
- |
|
| APTI |
Apptio Inc |
Director |
– • – |
2018-08-13 |
4 |
OE |
$9.01 |
$72,080 |
D/D |
8,000 |
21,334 |
0 |
- |
|
| APTI |
Apptio Inc |
Director |
– • – |
2018-09-10 |
4 |
AS |
$38.76 |
$310,065 |
D/D |
(8,000) |
13,334 |
0 |
- |
|
| APTI |
Apptio Inc |
Director |
– • – |
2018-09-10 |
4 |
OE |
$9.01 |
$72,080 |
D/D |
8,000 |
21,334 |
0 |
- |
|
| APTI |
Apptio Inc |
Director |
– • – |
2018-10-15 |
4 |
AS |
$29.90 |
$239,230 |
D/D |
(8,000) |
13,337 |
0 |
- |
|
| APTI |
Apptio Inc |
Director |
– • – |
2018-10-15 |
4 |
OE |
$9.01 |
$72,080 |
D/D |
8,000 |
21,337 |
0 |
- |
|
| APTI |
Apptio Inc |
Director |
– • – |
2018-11-12 |
4 |
AS |
$37.74 |
$301,882 |
D/D |
(8,000) |
13,337 |
0 |
- |
|
| APTI |
Apptio Inc |
Director |
– • – |
2018-11-12 |
4 |
OE |
$9.01 |
$72,080 |
D/D |
8,000 |
21,337 |
0 |
- |
|
| APTI |
Apptio Inc |
Director |
– • – |
2018-12-10 |
4 |
AS |
$37.82 |
$302,557 |
D/D |
(8,000) |
13,337 |
0 |
- |
|
| APTI |
Apptio Inc |
Director |
– • – |
2018-12-10 |
4 |
OE |
$9.01 |
$72,080 |
D/D |
8,000 |
21,337 |
0 |
- |
|
| APTI |
Apptio Inc |
Director |
– • – |
2019-01-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(13,337) |
0 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Director |
– • – |
2021-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,253 |
3,253 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Director |
– • – |
2021-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,074 |
5,327 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Director |
– • – |
2022-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
5,986 |
11,313 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Director |
– • – |
2023-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,216 |
15,529 |
0 |
- |
|
| FFIV |
F5 Networks Inc |
Director |
– • – |
2015-03-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
120 |
|
- |
|
| FFIV |
F5 Networks Inc |
Director |
– • – |
2016-03-09 |
4/A |
OE |
$0.00 |
$0 |
D/D |
2,212 |
2,332 |
0 |
- |
|
54 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
